 |
|
|
|
|
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Wilcock D. on PAPER: Zhu Y. et al., 2011, This is an interesting paper by Zhu and colleagues, who show that CD45 deletion in PSAPP... 1 Feb 2011.
|
|
|
 |
|
|
Wilcock D. on PAPER: Mori T. et al., 2010, The publication from Mori et al is an important paper. It adds to the growing body of evidence... 19 Sep 2009.
|
|
|
|
|
|
Wilcock D. on PAPER: Puzzo D. et al., 2009, This paper by Puzzo and colleagues presents some novel and interesting findings with respect to... 30 Jun 2009.
|
|
|
|
|
|
Wilcock D. on NEWS: AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons, The paper by Holmes et al. examines pathology and cognition of eight patients from the AN1792 Aβ... 18 Jul 2008.
|
|
|
|
|
|
Colton C, Van Nostrand W, Vitek M, Wilcock D. on PAPER: Wilcock DM. et al., 2008, Reply by CA Colton, DM Wilcock, J Oddo, WE Van Nostrand, MP Vitek, and D... 13 Mar 2008.
|
|
|
|
|
|
Colton C, Vitek M, Wilcock D. on NEWS: Popcorn Plaque? Alzheimer Disease Is Slow, Yet Plaque Growth Is Fast, Meyer-Luehmann and colleagues provide new insights into the temporal sequence of events... 14 Feb 2008.
|
|
|
|
|
|
Wilcock D. on NEWS: Immunotherapy Interrupted—Inflammation by Interferon, This is a very interesting paper from Monsonego and colleagues. It provides us with another... 21 Mar 2006.
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our most recent Webinar: 
